Latest Breaking News On - Molli surgical inc - Page 3 : comparemela.com
Breast Lesion Localization Methods Industry Trends, Revenue, Key Players, Growth, Share and Forecast Till 2028
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Breast Lesion Localization Methods Industry Trends, Revenue, Key Players, Growth, Share and Forecast Till 2028
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Molli Surgical Announces FDA Clearance for MOLLI Wire-free Localization Technology for Breast Cancer Surgery
Molli provides breast cancer patients with a better experience over traditional wire and other lesion localization options; the new device helps surgeons remove lesions more efficiently with accuracy and specificity
May 3, 2021 Molli Surgical Inc. announced U.S. Food and Drug Administration (FDA) clearance for Molli, a new wire-free localization technology for breast cancer surgery. The new technology helps radiologists mark lesions quickly and accurately, and enables surgeons to locate and remove lesions more efficiently while facilitating the best cosmetic results and a better patient experience.
“This year, alone, more than two million women around the globe will receive the devastating news that they have breast cancer,” said Fazila Seker, Ph.D., CEO of Molli Surgical. “Our mission is to make their journey smoother and support them along the way. Our new Mo
Share this article
Share this article
ResearchAndMarkets.com s offering.
The market for breast lesion localization methods is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period.
The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.
The COVID-19 pandemic has largely impacted healthcare delivery globally since December 2019. Non-essential procedures related to breast cancer care and routine breast screening programs have been postponed in many countries as healthcare resources are diverted to handle the pandemic crisis. The selection of the type of breast lesion localization method in the c